Search

everythinglearnresearchcommunity

for

Search:↓

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

New treatments for hair loss and excessive hair growth show promise with few side effects and advancements in laser technology.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Estrogen therapy can reduce skin aging but has cancer risks.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

UV rays can cause a type of hair loss known as telogen alopecia.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The long-pulsed alexandrite laser is effective for hair reduction, particularly for light-skinned individuals with dark hair, but caution is needed for darker skin.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Androgens can both increase body hair and cause scalp hair loss.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.